United States Eventing Association

Adequan® Renews Partnership with the USEA

Adequan^® returns as The Official Joint Therapy Treatment of the USEA and Title Sponsor of the $60,000 Adequan^® USEA Advanced Final for 2022.

The United States Eventing Association (USEA) would like to welcome back longtime sponsor American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final, and a Contributing Level Sponsor of the USEA American Eventing Championships (AEC), which takes place during the 2022 AEC, August 30 - September 4 at Rebecca Farm in Kalispell, Montana.

“We are extremely grateful for everything Adequan® does for the eventing community. They have supported U.S. Eventing for over 15 years, and they recently increased their support by offering unmatched prize money in the Adequan® USEA Advanced Final,” said USEA CEO Rob Burk. “We look forward to another year partnering with Adequan® as ‘The Official Joint Therapy of the USEA.’”

“For more than 30 years, Adequan® i.m. has supported horses and riders and we are thrilled to continue that legacy with the USEA” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We’re looking forward to another season of exciting competition in the sport of eventing.”

About the $60,000 Adequan® USEA Advanced Final

The $60,000 Adequan® USEA Advanced Final will take place at the 2022 USEA American Eventing Championships presented by Nutrena Feeds at Rebecca Farm in Kalispell, Montana August 30 – September 4, 2022. Thanks to Adequan’s amazing support, the Adequan^® USEA Advanced Final will bring together the country’s top riders to vie for $60,000 in prize money and the title of Adequan^® Champion. To qualify for the $60,000 Adequan® USEA Advanced Final at the AEC in 2022, competitors will need to complete a minimum of two events without cross-country jump penalties at any USEA recognized Advanced horse trials, CCI4*-S, CCI4*-L , or CCI5*-L . The qualifying period for the 2022 AEC is May 24, 2021 through August 22, 2022. Click here to learn more about the $60,000 Adequan® USEA Advanced Final.

About American Regent Animal Health

American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for over three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.